Irinotecan Liposomal

DRUG2 trials

Sponsors

Dai, Guanghai, The First Affiliated Hospital of Zhengzhou University

Conditions

Advanced Pancreatic Cancer (Part 1)Gastric Cancer

Phase 1

Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

RecruitingNCT06782685

Dai, GuanghaiAdvanced Pancreatic Cancer (Part 1)

Start: 2024-06-23End: 2027-03-31Target: 138Updated: 2025-01-20

Phase 2

Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer

Not yet recruitingNCT07085273

The First Affiliated Hospital of Zhengzhou UniversityGastric Cancer

Start: 2025-08-15End: 2027-06-30Target: 33Updated: 2025-07-31